Plasminogen Activator Inhibitor 1 Protects Fibrosarcoma Cells from Etoposide-Induced Apoptosis through Activation of the PI3K/Akt Cell Survival Pathway

Por Rømer, Maria U, Larsen, Lise, Offenberg, Hanne, Brünner, Nils, Lademann, Ulrik A
Publicado em 2008

The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells

Por Pedraz-Cuesta, Elena, Christensen, Sandra, Jensen, Anders A., Jensen, Niels Frank, Bunch, Lennart, Romer, Maria Unni, Brünner, Nils, Stenvang, Jan, Pedersen, Stine Falsig
Publicado no BMC Cancer (2015)

Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort

Por Smith, David Hersi, Christensen, Ib Jarle, Jensen, Niels Frank, Markussen, Bo, Rømer, Maria Unni, Nygård, Sune Boris, Müller, Sven, Nielsen, Hans Jørgen, Brünner, Nils, Nielsen, Kirsten Vang
Publicado em 2013

Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis

Por Rømer, Maria Unni, Nygård, Sune Boris, Christensen, Ib Jarle, Nielsen, Signe Lykke, Nielsen, Kirsten Vang, Müller, Sven, Smith, David Hersi, Vainer, Ben, Nielsen, Hans Jørgen, Brünner, Nils
Publicado no Mol Oncol (2012)

Tissue Inhibitor Of Matrix Metalloproteinase-1 Is Required for High-Fat Diet-Induced Glucose Intolerance and Hepatic Steatosis in Mice

Por Fjære, Even, Andersen, Charlotte, Myrmel, Lene Secher, Petersen, Rasmus Koefoed, Hansen, Jakob Bondo, Tastesen, Hanne Sørup, Mandrup-Poulsen, Thomas, Brünner, Nils, Kristiansen, Karsten, Madsen, Lise, Rømer, Maria Unni
Publicado no PLoS One (2015)

Host Plasminogen Activator Inhibitor-1 Promotes Human Skin Carcinoma Progression in a Stage-Dependent Manner

Por Maillard, Catherine, Jost, Maud, Rømer, Maria Unni, Brunner, Nils, Houard, Xavier, Lejeune, Annabelle, Munaut, Carine, Bajou, Khalid, Melen, Laurence, Dano, Keld, Carmeliet, Peter, Fusenig, Norbert E, Foidart, Jean Michel, Noel, Agnès
Publicado em 2005

Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations

Por Jensen, Niels Frank, Agama, Keli, Roy, Amit, Smith, David Hersi, Pfister, Thomas D., Rømer, Maria Unni, Zhang, Hong-Liang, Doroshow, James H., Knudsen, Birgitta R., Stenvang, Jan, Brünner, Nils, Pommier, Yves
Publicado no J Exp Clin Cancer Res (2016)

Impact of AT2 Receptor Deficiency on Postnatal Cardiovascular Development

Por Biermann, Daniel, Heilmann, Andreas, Didié, Michael, Schlossarek, Saskia, Wahab, Azadeh, Grimm, Michael, Römer, Maria, Reichenspurner, Hermann, Sultan, Karim R., Steenpass, Anna, Ergün, Süleyman, Donzelli, Sonia, Carrier, Lucie, Ehmke, Heimo, Zimmermann, Wolfram H., Hein, Lutz, Böger, Rainer H., Benndorf, Ralf A.
Publicado em 2012

High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer

Por Rasmussen, Mads H., Jensen, Niels F., Tarpgaard, Line S., Qvortrup, Camilla, Rømer, Maria U., Stenvang, Jan, Hansen, Tine P., Christensen, Lise L., Lindebjerg, Jan, Hansen, Flemming, Jensen, Benny V., Hansen, Torben F., Pfeiffer, Per, Brünner, Nils, Ørntoft, Torben F., Andersen, Claus L.
Publicado no Mol Oncol (2013)

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

Por Jensen, Niels F., Stenvang, Jan, Beck, Mette K., Hanáková, Barbora, Belling, Kirstine C., Do, Khoa N., Viuff, Birgitte, Nygård, Sune B., Gupta, Ramneek, Rasmussen, Mads H., Tarpgaard, Line S., Hansen, Tine P., Budinská, Eva, Pfeiffer, Per, Bosman, Fred, Tejpar, Sabine, Roth, Arnaud, Delorenzi, Mauro, Andersen, Claus L., Rømer, Maria U., Brünner, Nils, Moreira, José M.A.
Publicado no Mol Oncol (2015)